- Peter C Gøtzsche (p.c.gotzsche@cochrane.dk), Director,
- Helle Krogh Johansen, Senior researcher
- The Nordic Cochrane Centre, Rigshospitalet, Department 7112, Tagensvej 18 B, DK-2200 Copenhagen N, Denmark
EDITOR—In our meta-analysis we concluded that doses of prednisolone of ≤15 mg daily may be used intermittently in patients with rheumatoid arthritis, particularly if the disease cannot be controlled by other means.1
An accompanying editorial by Dennison and Cooper warned that doubts about the safety of this treatment remained.2 They also mentioned a number of side effects reported in a narrative review by Caldwell and Furst which we also cited in our meta-analysis (reference number 57). They complained that we had not subjected our …
Sign in
Personal subscribers, sign in here:
Article access
Article access for 1 day
Purchase this article for £20 $30 €32*
The PDF version can be downloaded as your personal record
CiteULike
Connotea
Del.icio.us
Digg
Facebook
Reddit
Technorati
Twitter
Stumbleupon
Rapid responses
Latest Responses
Ethical considerations
Published 14 February 2012
Re: Diagnosis and management of Raynaud’s phenomenon
Published 14 February 2012
Re: Raised inflammatory markers
Published 14 February 2012
Re: Physical activity for cancer survivors: meta-analysis of randomised controlled trials
Published 14 February 2012
Smokefree cars in Wales: Laws are better
Published 14 February 2012
Most responses
Does anyone understand the government’s plan for the NHS? (17 responses)
Published 17 Jan 2012
Bad medicine: medical nutrition (15 responses)
Published 18 Jan 2012
Shared decision making: really putting patients at the centre of healthcare (8 responses)
Published 27 Jan 2012
Why legislation is necessary for my health reforms (8 responses)
Published 1 Feb 2012
How much of a social media profile can doctors have? (7 responses)
Published 23 Jan 2012